|

Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section

RECRUITINGN/ASponsored by Benha University
Actively Recruiting
PhaseN/A
SponsorBenha University
Started2026-01-17
Est. completion2026-07-01
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted

Summary

This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Age over 18 years old.
* American Society of Anesthesiologists (ASA) physical status II.
* Scheduled for elective cesarean section (CS) delivery under Central Neuraxial Blockade.
* Provide informed consent and agree to participate in the study.

Exclusion Criteria:

* Patient's refusal
* Patient known have contraindications for Regional Anesthesia as infection at the site of injection, severe coagulopathy or allergy to local anesthetics.
* Patient with psychiatric disorders.
* Sensory impairment (blindness, deafness).
* Any technical problem preventing proper fitting of the glasses to the patient face.
* Patients with cognitive impairment, epilepsy or with claustrophobia
* Patients with suspected eye infection
* Signs of active labor.
* Pregnancy related-diseases or antepartum hemorrhage.
* Presence of Fetal distress.

Conditions8

AnxietyCesarean SectionDexmedetomidineHemodynamicsMaternal AnxietyNeonatal OutcomesStressVirtual Reality

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.